openPR Logo
Press release

Nicotinamide Market Competitive Landscape & Growth Opportunities 2017 - 2025

Nicotinamide Market

Nicotinamide Market

The world is facing tremendous increase in the incidence of diabetes mellitus, cardiac problems, and vitamin deficiency. For combating these challenges, cost-effective and complementary therapies are required. Diabetes has now been classified as a vascular disease and the cost of treating and controlling the micro-vascular component is a serious problem, specifically in developing countries. Niacinamide or nicotinamide is an essential vitamin and also an essential constituent of co-enzymes found in the mammalian systems. Nicotinamide is a member of the vitamin B complex. It is generally soluble in water. Deficiency of nicotinamide can be initially observed with symptoms such as weakness, indigestion, lassitude, anorexia, and irritability, which can lead to diarrhea and dementia. The chemical name of nicotinamide is 3-pyridinecarboxamide. It can be directly synthetized by the human body. In human body, nicotinamide is easily absorbed by the gastro-intestinal (GI) tract. Major dietary sources of nicotinamide are meat, milk, and grains. Physically, nicotinamide is a solid powder with water solubility of 691–1000 grams/liter and vapor pressure of 31.4 hPa at room temperature.

Browse Research Report With Complete TOC @ https://www.transparencymarketresearch.com/nicotinamide-market.html

Nicotinamide is a highly important ingredient used in food products to enhance their nutritional value. It is extensively used in bakery products, cereals, and beverages. It is also a type of dietary supplement. It is incorporated in supplements such as tablets and capsules. Nicotinamide is employed in cosmetics as a hair- and skin-conditioning agent. It is also used for the treatment of chronic schizophrenia, diabetes mellitus, and alcoholism. Nicotinamide is undergoing clinical trials for its antidiabetic and neuroprotective effects, so as to use it in pharmaceutical drugs.

Nicotinamide can be synthesized by using 3-picoline. Nicotinic acid or amide can be selectively oxidized to form nicotinamide, with the production of a carboxyl derivative and a few byproducts. The production of nicotinamide can be intensified by enzymatic conversion or biosynthesis. Nicotinamide is extensively employed in a variety of processes carried out in pharmaceuticals, cosmeceuticals, animal nutrition, metal brighteners, and metal plating industries. Nicotinamide is used in pharmaceutical applications that are meant for maintaining healthy cholesterol levels and sound heart functioning in humans. The increasing demand for nicotinic acid for use in various dietary supplements, food products, and pharmaceuticals is driving the global market for nicotinamide. Increasing incidence of coronary diseases and diabetes as well as decreasing nutritional value of food products demands for addition of nutritional value to dietary products. This is also a major reason for increased demand for nicotinamide. Threat from other organic chemicals, development of generic supplement ingredients, and fluctuations in prices of nicotinamide all over the world are major restraints for the nicotinamide market.

Developed regions such as North America and Europe witness the maximum consumption of nicotinamide. Industries such as pharmaceuticals, cosmetics, paints, and beverages are utilizing nicotinamide to improve the quality of their products. Southeast Asia is an expanding market for nicotinamide. The sub-region offers potential for growth of the nicotinamide market in Asia Pacific. Presently, China is the leading supplier of nicotinamide, followed by India and countries of North America and Europe.

Request a PDF Brochure with Research Report Analysis @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20735

Key global players that produce nicotinamide are Jubilant Life Sciences, Yurigose, Zhejiang Lanbo Biotechnology, LONZA, Vertellus, Nantong Acetic Acid Chemical Co., Ltd., Henan Xinyi Medicine group Fine Chemical Industry Company Ltd., Shanghai Jinhuan Chemical, and Brother. Jubilant Life Sciences leads the market in Asia in terms of production of nicotinamide. Growth of food processing and supplements industries has propelled the global nicotinamide market. Increasing incidence of coronary diseases and diabetes would also lead to major consumption of nicotinamide.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nicotinamide Market Competitive Landscape & Growth Opportunities 2017 - 2025 here

News-ID: 963417 • Views:

More Releases from Transparency Market Research

Global GLP-1 Analogues Market Poised for Transformational Growth, Projected to Reach US$ 211.8 Billion by 2035 | Transparency Market Research
Global GLP-1 Analogues Market Poised for Transformational Growth, Projected to R …
The global GLP-1 analogues market is entering a phase of unprecedented expansion, driven by the rising burden of type 2 diabetes and obesity, rapid innovation in drug formulations, and growing recognition of the cardiometabolic benefits of GLP-1-based therapies. According to the latest industry outlook, the market was valued at US$ 51.6 billion in 2024 and is projected to reach US$ 211.8 billion by 2035, registering a robust compound annual growth
Flow Chemistry Market to be Worth USD 5.9 Bn by 2035 - By Reactor Scale / By Reactor Type / By End-use Industry | U.S. • Germany • China • India
Flow Chemistry Market to be Worth USD 5.9 Bn by 2035 - By Reactor Scale / By Rea …
The global Flow Chemistry Market was valued at US$ 2.1 Billion in 2024 and is projected to reach US$ 5.9 Billion by 2035, expanding at a compound annual growth rate (CAGR) of 9.7% from 2025 to 2035. This strong growth trajectory reflects the increasing adoption of continuous manufacturing technologies across pharmaceuticals, fine and specialty chemicals, agrochemicals, and performance materials. Explore core findings and critical insights from our Report in this sample
Medical Simulation Market to See Breakthrough Growth, Approaching USD 13.1 Billion by 2034
Medical Simulation Market to See Breakthrough Growth, Approaching USD 13.1 Billi …
The medical simulation market has emerged as a critical pillar of modern healthcare education and training. Medical simulation refers to the use of advanced technologies such as manikins, virtual reality, augmented reality, task trainers, and software platforms to replicate real-world clinical scenarios in a controlled environment. These tools allow healthcare professionals to practice procedures, improve decision-making skills, and enhance teamwork without risking patient safety. As healthcare systems worldwide move toward
Building Automation and Control System Market Outlook 2035: Expanding from US$ 100.6 Billion to US$ 230.2 Billion by 2035 at a Robust 7.8% CAGR
Building Automation and Control System Market Outlook 2035: Expanding from US$ 1 …
The global building automation and control system (BACS) market is entering a decade of sustained expansion as digitalization, energy efficiency mandates, and smart infrastructure investments reshape the built environment. Valued at US$ 100.6 billion in 2024, the market is projected to reach US$ 230.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2035. This growth reflects the accelerating adoption of intelligent systems

All 5 Releases


More Releases for Nicotinamide

Track Nicotinamide Price Index Historical and Forecast
Nicotinamide Price Trend and Forecast Report - Global Market Insights, Regional Dynamics, and Procurement Outlook Executive Summary The global Nicotinamide (Vitamin B3) market showcased significant volatility from 2024 through Q3 2025, driven by shifting downstream demand patterns, stabilizing supply chains, evolving production cost structures, and fluctuating inventory positions across major regions. The market moved from the heightened price cycles of 2024 into a more deflationary environment through 2025, reflecting large supply availability,
Nicotinamide D4 Market Revenue, Insights, Overview, Outlook, Analysis
Nicotinamide D4 Market Nicotinamide-d4 is an analogue of nicotinamide, which is a vitamin found in food. It can be used to measure the amount of estrogens present in water and wastewater. Nicotinamide-d4 has been shown to have a stabilization effect on proteins. The global Nicotinamide D4 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast
Nicotinamide Mononucleotide Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Nicotinamide Mononucleotide Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Nicotinamide Mononucleotide players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Nicotinamide Mononucleotide with respect to individual growth
Nicotinamide Essence Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Nicotinamide Essence Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Nicotinamide Essence market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Nicotinamide Market with Regional Assessment of 2025
The world is facing tremendous increase in the incidence of diabetes mellitus, cardiac problems, and vitamin deficiency. For combating these challenges, cost-effective and complementary therapies are required. Diabetes has now been classified as a vascular disease and the cost of treating and controlling the micro-vascular component is a serious problem, specifically in developing countries. Niacinamide or nicotinamide is an essential vitamin and also an essential constituent of co-enzymes found in
Nicotinamide Market Global Market Opportunity Assessment Study 2025.
The world is facing tremendous increase in the incidence of diabetes mellitus, cardiac problems, and vitamin deficiency. For combating these challenges, cost-effective and complementary therapies are required. Diabetes has now been classified as a vascular disease and the cost of treating and controlling the micro-vascular component is a serious problem, specifically in developing countries. Niacinamide or nicotinamide is an essential vitamin and also an essential constituent of co-enzymes found in